150 related articles for article (PubMed ID: 27513518)
1. Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin.
Nemudraya AA; Makartsova AA; Fomin AS; Nushtaeva AA; Koval OA; Richter VA; Kuligina EV
PLoS One; 2016; 11(8):e0160980. PubMed ID: 27513518
[TBL] [Abstract][Full Text] [Related]
2. Selection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptin.
Nemudraya AA; Kuligina EV; Ilyichev AA; Fomin AS; Stepanov GA; Savelyeva AV; Koval OA; Richter VA
Oncol Lett; 2016 Dec; 12(6):4547-4555. PubMed ID: 28105163
[TBL] [Abstract][Full Text] [Related]
3. Lactaptin induces p53-independent cell death associated with features of apoptosis and autophagy and delays growth of breast cancer cells in mouse xenografts.
Koval OA; Tkachenko AV; Fomin AS; Semenov DV; Nushtaeva AA; Kuligina EV; Zavjalov EL; Richter VA
PLoS One; 2014; 9(4):e93921. PubMed ID: 24710119
[TBL] [Abstract][Full Text] [Related]
4. A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice models.
Koval OA; Fomin AS; Kaledin VI; Semenov DV; Potapenko MO; Kuligina EV; Nikolin VP; Nikitenko EV; Richter VA
Biochimie; 2012 Dec; 94(12):2467-74. PubMed ID: 22968174
[TBL] [Abstract][Full Text] [Related]
5. [Immunogenicity of recombinant analog of antitumor protein lactaptin].
Tkachenko AV; Troitskaya OS; Semenov DV; Dmitrienko EV; Kuligina EV; Richter VA; Koval OA
Mol Biol (Mosk); 2017; 51(5):787-796. PubMed ID: 29116065
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors.
Bagamanshina AV; Troitskaya OS; Nushtaeva AA; Yunusova AY; Starykovych MO; Kuligina EV; Kit YY; Richter M; Wohlfromm F; Kähne T; Lavrik IN; Richter VA; Koval OA
Biomed Res Int; 2019; 2019():4087160. PubMed ID: 31317028
[TBL] [Abstract][Full Text] [Related]
7. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
Lao X; Li B; Liu M; Shen C; Yu T; Gao X; Zheng H
Apoptosis; 2015 Oct; 20(10):1307-20. PubMed ID: 26283169
[TBL] [Abstract][Full Text] [Related]
8. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
Kochneva G; Sivolobova G; Tkacheva A; Grazhdantseva A; Troitskaya O; Nushtaeva A; Tkachenko A; Kuligina E; Richter V; Koval O
Oncotarget; 2016 Nov; 7(45):74171-74188. PubMed ID: 27708236
[TBL] [Abstract][Full Text] [Related]
9. Recombinant analogs of a novel milk pro-apoptotic peptide, lactaptin, and their effect on cultured human cells.
Semenov DV; Fomin AS; Kuligina EV; Koval OA; Matveeva VA; Babkina IN; Tikunova NV; Richter VA
Protein J; 2010 Apr; 29(3):174-80. PubMed ID: 20232123
[TBL] [Abstract][Full Text] [Related]
10. The purification and identification of human blood serum proteins with affinity to the antitumor active RL2 lactaptin using magnetic microparticles.
Manko N; Starykovych M; Bobak Y; Stoika R; Richter V; Koval O; Lavrik I; Horák D; Souchelnytskyi S; Kit Y
Biomed Chromatogr; 2019 Nov; 33(11):e4647. PubMed ID: 31299101
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of endometrial cancer cells from primary human tumor samples to new potential anticancer peptide lactaptin.
Koval OA; Sakaeva GR; Fomin AS; Nushtaeva AA; Semenov DV; Kuligina EV; Gulyaeva LF; Gerasimov AV; Richter VA
J Cancer Res Ther; 2015; 11(2):345-51. PubMed ID: 26148598
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Lactaptin Induces Immunogenic Cell Death and Creates an Antitumor Vaccination Effect in Vivo with Enhancement by an IDO Inhibitor.
Troitskaya O; Varlamov M; Nushtaeva A; Richter V; Koval O
Molecules; 2020 Jun; 25(12):. PubMed ID: 32560527
[TBL] [Abstract][Full Text] [Related]
13. [The analysis of biochemical markers of MCF-7 cells apoptosis induced by recombinant analog of lactaptin].
Fomin AS; Koval' OA; Semenov DV; Potapenko MO; Kuligina EV; Kit IuIa; Rikhter VA
Bioorg Khim; 2012; 38(1):92-8. PubMed ID: 22792711
[TBL] [Abstract][Full Text] [Related]
14. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
[TBL] [Abstract][Full Text] [Related]
15. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
[TBL] [Abstract][Full Text] [Related]
16. Structural and Aggregation Features of a Human κ-Casein Fragment with Antitumor and Cell-Penetrating Properties.
Chinak OA; Shernyukov AV; Ovcherenko SS; Sviridov EA; Golyshev VM; Fomin AS; Pyshnaya IA; Kuligina EV; Richter VA; Bagryanskaya EG
Molecules; 2019 Aug; 24(16):. PubMed ID: 31408975
[TBL] [Abstract][Full Text] [Related]
17. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
18. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
19. An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells.
Zhang Z; Hou L; Feng L; Huang S; Luo M; Shao S; Zhang X; Gu S; Zhao X
Tumour Biol; 2015 Sep; 36(10):8167-75. PubMed ID: 25990455
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]